Skip to main content
. 2019 Jan 2;9(1):7. doi: 10.3390/metabo9010007

Table 1.

Panel of significantly altered metabolites 2 days after dosing with palbociclib (n = 4), fulvestrant (n = 4) or a combination dose of both palbociclib and fulvestrant (n = 4) when comparing dosed groups to control. Values are log transformed fold changes after quantification by multiple reaction monitoring, unpaired two-tailed t-test.

Metabolite Name Palbociclib Fulvestrant Combination
Fold Change p-Value Fold Change p-Value Fold Change p-Value
Succinate 1.6 0.0025 1.8 0.0441 1.9 0.0021
Malate −4.0 0.0170 −3.5 0.0381 −34.0 0.0002
Fumarate −2.1 0.0189 −2.1 0.0438 −2.0 0.0003
Phosphoenolpyruvate 1.1 0.0450 N.S N.S 1.2 0.0014
6-phosphogluconate N.S N.S −3.7 0.0255 −2.5 0.0496
Sedoheptulose-7-phosphate N.S N.S −3.6 0.0335 −3.7 0.0003
Serine N.S N.S 1.7 <0.0001 N.S N.S
Cholesterol sulfate N.S N.S −5.2 0.0332 N.S N.S
Taurine N.S N.S −2.1 0.0380 N.S N.S
Inosine monophosphate N.S N.S N.S N.S −16.1 0.0052
Fructose-1-phosphate N.S N.S N.S N.S −2.8 0.0172